Introduction Foodborne botulism is caused by the anaerobic bacterial agent-Clostridium botulinum-that is a gram-positive bacteria (1) and one of the most common life-threatening agents in the United States, Europe and Iran (2-4). In 2011, 140 cases of botulism were reported to the US Centers for Disease Control and Prevention which 14% of cases were due to food-borne botulism (5). Seven types of clostridium named A-G are studied (6) in which A, B, E, and F are the main potent poisoning types in human that produce botulinum neurotoxin (BoNT). These types of clostridium get absorbed in GI after ingestion and may lead to morbidities such as paralysis and mortality, although their toxins are sensitive to heat (4,7). Mostly, foodborne botulism is associated with consuming canned tuna fish, home-preserved or commercial food which contain vegetables (4,8-10). C. botulism releases neurotoxins into the blood and they bind to cells and lead to the impairment of the voluntary motor presynaptic cholinergic receptors and autonomic neuromuscular junctions (11-13). This leads to dizziness, blurred vision, slurred speech, ptosis (14) descending flaccid paralysis and respiratory failure because of the failure of transmission (11-13). All in all, the clinical symptoms can be observed after an incubation period and they are dependent on the serotype and degree of exposure to the toxin (15,16). Therefore, clinical findings are the principal key to the early diagnosis of botulism (2). Case Presentation A 48-year-old Caucasian woman referred to the emergency department complaining about acute dysphonia accompanied with dysarthria which cooccurred with dizziness, progressive symmetric hypotonia in upper and lower limbs, dilated pupils, facial paresthesia and bilateral ptosis. She had no dysphagia, fever, respiratory distress or vertigo. She had a history of consuming local dairy cheese. Based on clinical findings, the patient was admitted with the impression of botulinum intoxication. Botulism anti-toxin was administered. One vial of tetravalent botulism antitoxin was given intravenously as a 1:10 vol/vol dilution in 0.9% sodium chloride TDS. Since the most common cause of mortality is respiratory failure (17), supportive care was prepared and O 2 therapy, cardiac monitoring, pulse oximetry, and rapid sequence intubation equipment were considered and prepared in case of necessity. To rule out other probable causes, a neurology consult was requested. Blood and feces sample were taken and the probable occurrence of botulism was informed to the Health Center. The patient gradually became better. On the fifth day, the patient still had dysphonia and perioral paresthesia. She was hospitalized